跳至主要内容
临床试验/NCT05569135
NCT05569135已完成不适用

Debridement and Laser Ablation Versus Debridement Alone in Pilonidal Disease: Retrospective Analysis of Mid-term Outcome

Istanbul Medipol University Hospital1 个研究点 分布在 1 个国家目标入组 121 人开始时间: 2018年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
121
试验地点
1
主要终点
disease recurrence at 36 months

研究概览

简要总结

This study aims to investigate the effect of laser ablation (LA) in minimally invasive management of pilonidal disease (PD).

Data of the patients with PD who were eligible for simple debridement have been prospectively collected since March 2018, when laser ablation treatment came into use in our institution. Laser ablation treatment was offered to all eligible patients. All the patients underwent debridement (removal of hair and/or necrotic tissues through pits using a clamp/curette/brush) of PD; LA was added to the procedure in patients who were willing to have LA. The surgical outcome of two procedures was compared. The primary outcome measure was recurrence at 36 months.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with Class III, IV, and V pilonidal disease according to Tezel Navicular Area Classification
  • Patients who underwent debridement for pilonidal disease

排除标准

  • Patients with acute abscess (Tezel Class II)
  • Antibiotic use within 4 weeks before surgery
  • Patients lost to follow-up at 3,7 and 30 days; 6, 12 and 36 months

结局指标

主要结局

disease recurrence at 36 months

时间窗: 36 months

Any ongoing or recurrent sypmtoms were recorded

次要结局

  • Complications after the procedure(1 month)
  • Incidence of adverse events(1 month)

研究者

发起方
Istanbul Medipol University Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验